J&J’s Spravato receives FDA label expansion for depression monotherapy
Johnson & Johnson’s (J&J) nasal spray Spravato (esketamine) has received a label expansion, now approved as a monotherapy ...
mic44m
A Nasal Spray For Depression? FDA Gives Its Approval
The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson's nasal spray, Spravato (esketamine), as the first ...
India Today on MSN1h
US FDA approves new nasal spray for depression treatment: All about it
The newly FDA-approved nasal spray called Spravato is being manufactured by Johnson & Johnson's and is a standalone treatment ...
Nose spray to treat depression? FDA approves first-of-its-kind medicine
The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday ...
ENDPOINTS NEWS40m
J&J’s Spra­va­to hit $1B in rev­enue in 2024
J&J's depression drug Spravato hits $1B in 2024 sales, up 56% from 2023, with expanded label approval and 140,000+ patients ...
WJCT5m
Trump strips immigration enforcement protections. And, Hegseth battles new claims
Trump's administration has cleared the way for arrests in schools of people suspected of being without legal status. And, ...
Low water pressure reported in Village of Tangipahoa Parish
Julie McFadden has cared for over 100 patients in their final days. As President Donald Trump’s health care agenda for a ...